Grand Pharma Receives Green Light for Phase III Trials of Cancer Drug
Grand Pharma Receives Green Light for Phase III Trials of Cancer Drug
Grand Pharma 獲得 III 期抗癌藥物試驗的批准
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊